Ligand · AGY
AGY · 2-[(4-tert-butyl-3-nitrophenyl)carbonyl]-N-naphthalen-1-ylhydrazinecarboxamide
AGY, 2-[(4-tert-butyl-3-nitrophenyl)carbonyl]-N-naphthalen-1-ylhydrazinecarboxamide (C22 H22 N4 O4, 406.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å…
- Component
- AGY
- Formula
- C22 H22 N4 O4
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
AGY in 2 structures; the first of them:
- 3JVS · Characterization of the Chk1 allosteric inhibitor binding site · AGY A900 · binds PHE93, ASP94, ARG95, ILE96, GLU97, PRO98, PRO133, GLU134 and 5 more
- 3JVS · Characterization of the CHK1 allosteric inhibitor binding site · AGY A900 · binds PHE93, ASP94, ARG95, ILE96, GLU97, PRO98, PRO133, GLU134 and 5 more
Residues it binds most
GLU 2, PRO 2, ALA 2, ARG 2, ASP 2, GLY 2, ILE 2, LEU 2, PHE 2, TYR 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.